CDK 4/6 Inhibitors in High-Risk Early Breast Cancer

home / peer-exchange / cdk-4-6-inhibitors-in-high-risk-early-breast-cancer

A panel of medical experts explore CDK 4/6 inhibitors for patients diagnosed with high-risk early breast cancer.

Episodes

CH LogoCenter for Biosimilars Logo